186 related articles for article (PubMed ID: 22850268)
1. The efficacy and safety of 12 weeks of treatment with sertindole or olanzapine in patients with chronic schizophrenia who did not respond successfully to their previous treatments: a randomized, double-blind, parallel-group, flexible-dose study.
Kwon JS; Mittoux A; Hwang JY; Ong A; Cai ZJ; Su TP
Int Clin Psychopharmacol; 2012 Nov; 27(6):326-35. PubMed ID: 22850268
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia.
Azorin JM; Strub N; Loft H
Int Clin Psychopharmacol; 2006 Jan; 21(1):49-56. PubMed ID: 16317317
[TBL] [Abstract][Full Text] [Related]
3. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
[TBL] [Abstract][Full Text] [Related]
4. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
Simpson GM; Glick ID; Weiden PJ; Romano SJ; Siu CO
Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981
[TBL] [Abstract][Full Text] [Related]
5. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
Nielsen J; Emborg C; Gydesen S; Dybbro J; Aagaard J; Haderup K; Glyngdal P; Fabricius S; Thode D; Lublin H; Andersen T; Damkier P; Taylor D
J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of sertindole in schizophrenia: a clinical review.
Zoccali RA; Bruno A; Muscatello MR
J Clin Psychopharmacol; 2015 Jun; 35(3):286-95. PubMed ID: 25830594
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.
Kryzhanovskaya L; Schulz SC; McDougle C; Frazier J; Dittmann R; Robertson-Plouch C; Bauer T; Xu W; Wang W; Carlson J; Tohen M
J Am Acad Child Adolesc Psychiatry; 2009 Jan; 48(1):60-70. PubMed ID: 19057413
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
Daniel DG; Wozniak P; Mack RJ; McCarthy BG
Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
[TBL] [Abstract][Full Text] [Related]
9. Drug safety and efficacy evaluation of sertindole for schizophrenia.
Karamatskos E; Lambert M; Mulert C; Naber D
Expert Opin Drug Saf; 2012 Nov; 11(6):1047-62. PubMed ID: 22992213
[TBL] [Abstract][Full Text] [Related]
10. Sertindole in the long-term treatment of schizophrenia.
Hale AS; Azorin JM; Lemming OM; Mæhlum E
Int Clin Psychopharmacol; 2012 Jul; 27(4):231-7. PubMed ID: 22609816
[TBL] [Abstract][Full Text] [Related]
11. Sertindole: efficacy and safety in schizophrenia.
Lindström E; Levander S
Expert Opin Pharmacother; 2006 Sep; 7(13):1825-34. PubMed ID: 16925508
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.
McEvoy JP; Lieberman JA; Perkins DO; Hamer RM; Gu H; Lazarus A; Sweitzer D; Olexy C; Weiden P; Strakowski SD
Am J Psychiatry; 2007 Jul; 164(7):1050-60. PubMed ID: 17606657
[TBL] [Abstract][Full Text] [Related]
13. Cardiac effects of sertindole and quetiapine: analysis of ECGs from a randomized double-blind study in patients with schizophrenia.
Nielsen J; Matz J; Mittoux A; Polcwiartek C; Struijk JJ; Toft E; Kanters JK; Graff C
Eur Neuropsychopharmacol; 2015 Mar; 25(3):303-11. PubMed ID: 25583364
[TBL] [Abstract][Full Text] [Related]
14. Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia.
Casey DE; Daniel DG; Tamminga C; Kane JM; Tran-Johnson T; Wozniak P; Abi-Saab W; Baker J; Redden L; Greco N; Saltarelli M
Neuropsychopharmacology; 2009 Apr; 34(5):1330-8. PubMed ID: 19052541
[TBL] [Abstract][Full Text] [Related]
15. A review of the efficacy, tolerability and safety of sertindole in clinical trials.
Perquin L; Steinert T
CNS Drugs; 2004; 18 Suppl 2():19-30; discussion 41-3. PubMed ID: 15461313
[TBL] [Abstract][Full Text] [Related]
16. Sertindole: dilemmas for its use in clinical practice.
Pae CU
Expert Opin Drug Saf; 2013 May; 12(3):321-6. PubMed ID: 23432404
[TBL] [Abstract][Full Text] [Related]
17. Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study.
Meltzer HY; Cucchiaro J; Silva R; Ogasa M; Phillips D; Xu J; Kalali AH; Schweizer E; Pikalov A; Loebel A
Am J Psychiatry; 2011 Sep; 168(9):957-67. PubMed ID: 21676992
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.
Kinon BJ; Stauffer VL; Kollack-Walker S; Chen L; Sniadecki J
J Clin Psychopharmacol; 2008 Dec; 28(6):601-7. PubMed ID: 19011427
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia.
Dossenbach MR; Folnegovic-Smalc V; Hotujac L; Uglesic B; Tollefson GD; Grundy SL; Friedel P; Jakovljevic MM;
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):311-8. PubMed ID: 14751428
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
Kane JM; Potkin SG; Daniel DG; Buckley PF
J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
